TrialEsophagus : official journal of the Japan Esophageal Society2022

Multicenter phase II study of trifluridine/tipiracil for esophageal squamous carcinoma refractory/intolerant to 5-fluorouracil, platinum compounds, and taxanes: the ECTAS study.

Yukiko Mori et al.PubMed ↗Publisher ↗

No numbers read from the abstract.